Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Bulletin Du Cancer|November 17, 2004
[Fluorinated analogs of nucleosides and fluorinated tracers of gene expression for positron emission tomography]Olivier Couturier, Jean-François Chatal, Roland HustinxCurrent Pharmaceutical Design|July 16, 2009
Current status and perspectives in peptide receptor radiation therapyCatherine Ansquer, Françoise Kraeber-Bodéré, Jean François ChatalMedecine Sciences : M/S|December 29, 2009
[Radiolabeled antibodies for cancer treatment]Jacques Barbet, Jean-François Chatal, Françoise Kraeber-BodéréCancer Biotherapy & Radiopharmaceuticals|September 6, 2008
What can be expected from nuclear medicine tomorrow?Jacques Barbet, Françoise Kraeber-Bodéré, Jean-François ChatalThe Journal of Clinical Endocrinology and Metabolism|August 11, 2005
Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinomaJacques Barbet, Loïc Campion, Françoise Kraeber-Bodéré, et al.Bulletin Du Cancer|October 6, 2005
[Is 3'-deoxy-3'- [18F] fluorothymidine ([18F]-FLT) the next tracer for routine clinical PET after R [18F]-FDG?]Olivier Couturier, Françoise Leost, Mario Campone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2005
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapyDavid M Goldenberg, Robert M Sharkey, Giovanni Paganelli, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2004
Fluorinated tracers for imaging cancer with positron emission tomographyOlivier Couturier, André Luxen, Jean-François Chatal, et al.Frontiers in Medicine|October 7, 2015
Story of Rubidium-82 and Advantages for Myocardial Perfusion PET ImagingJean-François Chatal, François Rouzet, Ferid Haddad, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 10, 2008
ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicineFerid Haddad, Ludovic Ferrer, Arnaud Guertin, et al.Pageof 4